Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2013
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 May 2012 Planned End Date changed from 1 Feb 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 09 Dec 2009 Planned end date changed from 1 Sep 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History